Abstract
BackgroundThe treatment of EF is still a challenge for rheumatologists.ObjectivesTo report our experience with fourteen EF patients on MTX followed over a period of 1 to 14 years in the...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have